Finerenone and Empagliflozin Combination in Obesity With Hypertension: A 12-Week Prospective, Parallel-design, Double-blind, Randomized, Placebo-controlled Trial
Clinical trial NCT07678151 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07678151
- Sponsor
- Heart Health Research Center
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-13
- Primary completion
- 2027-04-30
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.